Literature DB >> 16772008

Participation in three consecutive mass drug administrations in Leogane, Haiti.

Els Mathieu1, Abdel N Direny, Madsen Beau de Rochars, Thomas G Streit, David G Addiss, Patrick J Lammie.   

Abstract

OBJECTIVES: In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non-compliant and factors associated with this behaviour.
METHODS: We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non-compliance and associated factors and (3) an urban survey to make a rural-urban comparison.
RESULTS: During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4-82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0-66.7), 61.0% (95% CI 55.0-67.4) and 67.3% (95% CI 60.5-74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the population > 14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
CONCLUSION: More research is needed to identify characteristics of systematically non-compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772008     DOI: 10.1111/j.1365-3156.2006.01626.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  21 in total

1.  A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.

Authors:  Brittany A Eddy; Anna J Blackstock; John M Williamson; David G Addiss; Thomas G Streit; Valery M Beau de Rochars; Leanne M Fox
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

2.  A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.

Authors:  Alexis Boyd; Kimberly Y Won; Shannon K McClintock; Catherine V Donovan; Sandra J Laney; Steven A Williams; Nils Pilotte; Thomas G Streit; Madsen V E Beau de Rochars; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

3.  The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

Authors:  Maged El-Setouhy; Khaled M Abd Elaziz; Hanan Helmy; Hoda A Farid; Hussein A Kamal; Reda M R Ramzy; William D Shannon; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

4.  Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.

Authors:  Dominique Kyelem; Gautam Biswas; Moses J Bockarie; Mark H Bradley; Maged El-Setouhy; Peter U Fischer; Ralph H Henderson; James W Kazura; Patrick J Lammie; Sammy M Njenga; Eric A Ottesen; Kapa D Ramaiah; Frank O Richards; Gary J Weil; Steven A Williams
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

5.  Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.

Authors:  Khaled M Abd Elaziz; Maged El-Setouhy; Mark H Bradley; Reda M R Ramzy; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2013-06-10       Impact factor: 2.345

6.  Assessing the impact of a missed mass drug administration in Haiti.

Authors:  Kimberly Y Won; Madsen Beau de Rochars; Dominique Kyelem; Thomas G Streit; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

7.  Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.

Authors:  Clare Huppatz; Corinne Capuano; Kevin Palmer; Paul M Kelly; David N Durrheim
Journal:  BMC Infect Dis       Date:  2009-06-12       Impact factor: 3.090

8.  Endpoints for lymphatic filariasis programs.

Authors:  Caroline A Grady; Madsen Beau de Rochars; Abdel N Direny; Jean Nicolas Orelus; Joyanna Wendt; Jeanne Radday; Els Mathieu; Jacquelin M Roberts; Thomas G Streit; David G Addiss; Patrick J Lammie
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

9.  Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings.

Authors:  Naomi Drexler; Charles H Washington; Maribeth Lovegrove; Caroline Grady; Marie Denise Milord; Thomas Streit; Patrick Lammie
Journal:  PLoS Negl Trop Dis       Date:  2012-10-11

Review 10.  Spatial parasite ecology and epidemiology: a review of methods and applications.

Authors:  Rachel L Pullan; Hugh J W Sturrock; Ricardo J Soares Magalhães; Archie C A Clements; Simon J Brooker
Journal:  Parasitology       Date:  2012-07-19       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.